Neurology News

CHICAGO — Low-income and underrepresented populations are at greater risk for neurodevelopmental effects related to chemical exposures, according to an expert at the 2022 American Neurological Association annual meeting.

CHICAGO — Divyanshu Dubey, MBBS, discusses the use of antibody evaluations in the workup for neuropathies during a presentation at the 2022 American Neurological Association’s annual meeting.

CHICAGO — Igor J. Koralnik, MD, discusses highlights from his presentation at the 2022 American Neurological Association’s annual meeting on long COVID and its effect on the nervous system.

CHICAGO — Older age at symptom onset and select pathologies were associated with shorter symptom duration in patients with rapidly progressive dementia, according to a poster at ANA 2022.

Published results showed use of a novel hip brace was effective for preventing progression of hip displacement and improving quality of life in patients with nonambulatory cerebral palsy.

CHICAGO — Roy H. Hamilton, MD, MS, discusses a symposium at the 2022 American Neurological Association’s annual meeting that focused on Alzheimer’s disease and MS and the disproportionate burden that underrepresented groups experience.

CHICAGO — Environmental chemical exposure is a risk factor for neurodegenerative diseases and neurodevelopmental disorders, an expert at the 2022 American Neurological Association annual meeting said.

The CDC has released updated and expanded clinical practice guidance on prescribing opioids to patients with short- and long-term pain.

Study results found a 1-year mortality rate of 13.4% after major surgery among community-living older adults in the United States, with the highest mortality rates seen in those who were frail and had probable dementia.

In this edition, we bring you news and Healio-exclusive interviews from the American Neurological Association Annual Meeting.